ClinConnect ClinConnect Logo
Search / Trial NCT06784817

Investigating the Periodontal Status of Traditional and Heated Tobacco Product Users

Launched by SEMMELWEIS UNIVERSITY · Jan 15, 2025

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

Smoking Heated Tobacco Products Periodontal Diseases

ClinConnect Summary

This clinical trial is looking at the effects of different tobacco products on oral health, specifically focusing on gum disease and related issues. Researchers want to compare the dental health of three groups: people who smoke cigarettes, those who use heated tobacco products (like IQOS), and non-smokers. They will examine factors such as gum depth, bleeding, plaque, and bone loss around the teeth to see if tobacco users have more problems than non-smokers.

To participate in this study, you need to be between 65 and 74 years old and fall into one of three groups: you must be a regular cigarette smoker, an exclusive heated tobacco user, or a non-smoker who has never used tobacco. Participants will undergo dental examinations, and the study is currently recruiting individuals who meet these criteria. Importantly, people with certain health conditions or those who have recently taken specific medications, among other exclusions, cannot participate. This study aims to shed light on how different forms of tobacco impact gum health, which is an important aspect of overall well-being.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Smokers who smoke at least one cigarette daily for the past 12 months.
  • Exclusive users of heated tobacco products (e.g., IQOS), using them at least once daily for the past 12 months and not regular traditional cigarette smokers.
  • Non-smokers who have never consumed tobacco in any form.
  • Exclusion Criteria:
  • Users of electronic cigarettes, smokeless tobacco, waterpipes, or any other tobacco products.
  • Dual users of tobacco products.
  • Individuals diagnosed with systemic diseases.
  • Edentulousness or severe tooth loss (fewer than 20 remaining teeth).
  • Individuals who have taken antibiotics, steroids, or non-steroidal anti-inflammatory drugs in the past 90 days.
  • Pregnant or breastfeeding women.
  • History of periodontitis.
  • Individuals refusing to sign the written informed consent form.
  • Third molars are excluded from examination.

About Semmelweis University

Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.

Locations

Budapest, Pest, Hungary

Patients applied

0 patients applied

Trial Officials

Barbara Kispélyi, Dental

Study Director

Semmelweis University, Department of Prosthodontics

Kata Kelemen, Dental

Study Director

Semmelweis University, Department of Prosthodontics

Brigitta Teutsch, Medical doctor

Study Chair

Center for Translational Medicine, Semmelweis University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported